Carl Arneson

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

Ángel Crespo López, José A. Lorente, Jay S. Steingrub et al. · Critical Care Medicine · 2004 · 917 citations

Beraprost therapy for pulmonary arterial hypertension

Robyn J. Barst, Michael D. McGoon, Vallerie V. McLaughlin et al. · Journal of the American College of Cardiology · 2003 · 629 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +9

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)

Victor F. Tapson, Fernando Torres, F. Kermeen et al. · CHEST Journal · 2012 · 374 citations

Freedom-c Study, Hypertension, Pulmonary Arterial Hypertension +11

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil

R. J. Barst, Nazzareno Galiè, Robert Naeije et al. · European Respiratory Journal · 2006 · 333 citations · Full text

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension

Zhi‐Cheng Jing, Keyur Parikh, Tomás Pulido et al. · Circulation · 2013 · 316 citations · Full text